Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Bioorg Med Chem. 2008 Dec 24;17(3):1222–1231. doi: 10.1016/j.bmc.2008.12.025

Figure 4.

Figure 4

Percent survival of MDA-MB435 cells treated with WC-26 for 16 h, followed by a combination of WC-26 and doxorubicin (DOX) for an additional 24 h. The data points represent the mean ± 1 SD of triplicate samples in a representative experiment.